Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca<sup>2+</sup>/Calcineurin/p-NFATc3 Pathway

<div>Extracellular Ca<sup>2+</sup> concentration of cardiomyocytes in groups.</div>

Journal of Healthcare Engineering

Figure 4: Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca<sup>2+</sup>/Calcineurin/p-NFATc3 Pathway 